A double-blind, cross-over patient preference study of frovatriptan versus zolmitriptan for the acute treatment of migraine
Phase of Trial: Phase IV
Latest Information Update: 12 Jul 2019
Price : $35 *
At a glance
- Drugs Frovatriptan (Primary) ; Zolmitriptan
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Menarini
- 15 Jun 2019 This trial has been completed in Spain, according to European Clinical Trials Database.
- 15 Jun 2019 Status changed from recruiting to completed.
- 12 Oct 2016 This trial is completed in Ireland (End date: 2008-11-03) as per European Clinical Trials Database record.